secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001193125-26-007660
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phathom Pharmaceuticals prices $130M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- 6,875,000 shares of common stock at $16.00/share and pre-funded warrants for 1,250,078 shares at $15.999/warrant.
- Gross proceeds approximately $130M; underwriters have 30-day option for additional 1,218,761 shares.
- Net proceeds for general corporate purposes, including working capital and R&D.
- Offering expected to close on/about January 9, 2026; Guggenheim Securities and Cantor are joint bookrunners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312526007660/0001193125-26-007660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312526007660/d680858d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-007660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer